Cargando…

MRI-Monitored Intra-Shunt Local Agent Delivery of Motexafin Gadolinium: Towards Improving Long-Term Patency of TIPS

BACKGROUND: Transjugular intrahepatic portosystemic shunt (TIPS) has become an important and effective interventional procedure in treatment of the complications related to portal hypertension. Although the primary patency of TIPS has been greatly improved due to the clinical application of cover st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Han, Zhang, Feng, Meng, Yanfeng, Zhang, Tong, Willis, Patrick, Le, Thomas, Soriano, Stephanie, Ray, Erik, Valji, Karim, Zhang, Guixiang, Yang, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585394/ https://www.ncbi.nlm.nih.gov/pubmed/23468986 http://dx.doi.org/10.1371/journal.pone.0057419

Ejemplares similares

Motexafin gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer
por: Thomas, Sayana R, et al.
Publicado: (2007)

Noninvasive CSF shunt patency evaluation by superb microvascular imaging
por: Putzer, D., et al.
Publicado: (2023)

Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents
por: Ringler, Michael D., et al.
Publicado: (2021)

Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt
por: Luo, Shi-Hua, et al.
Publicado: (2017)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010)

Assessment Lumboperitoneal or Ventriculoperitoneal Shunt Patency by Radionuclide Technique: A Review Experience Cases
por: Chiewvit, Sunanta, et al.
Publicado: (2014)

Transjugular Intrahepatic Portosystemic Shunt for Maintenance of Portal Venous Patency in Liver Transplant Candidates
por: Gaba, Ron Charles, et al.
Publicado: (2013)

Gadolinium-enhanced MRI visualizing backflow at increasing intra-renal pressure in a porcine model
por: Lildal, Søren Kissow, et al.
Publicado: (2023)

Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency
por: Dong, Fang, et al.
Publicado: (2019)

Revisiting the risks of MRI with Gadolinium based contrast agents—review of literature and guidelines
por: Khawaja, Aurang Z., et al.
Publicado: (2015)

Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma
por: Patil, Rameshwar, et al.
Publicado: (2020)

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents
por: Gallo, Enrico, et al.
Publicado: (2020)

The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014)

Utility of bronchoscopic intra-tumoral alcohol injection to restore airway patency
por: Jantz, Michael A., et al.
Publicado: (2021)

Percutaneous creation of direct intrahepatic portosystemic shunts – an alternative for failed TIPS creation
por: Mostafa, Karim, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt creation via isolated persistent left superior vena cava: a case series
por: Lewis, Spencer B., et al.
Publicado: (2020)

Fatal anaphylactic reaction to intravenous gadobutrol, a gadolinium-based MRI contrast agent
por: Franckenberg, Sabine, et al.
Publicado: (2017)

Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis
por: Jeong, Yohan, et al.
Publicado: (2018)

Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents
por: Hojreh, Azadeh, et al.
Publicado: (2020)

Gadolinium-doped fluorescent carbon quantum dots as MRI contrast agents and fluorescent probes
por: Molaei, Mohammad Jafar
Publicado: (2022)

Gadolinium-Based Contrast Agents in Pregnant Women: A Literature Review of MRI Safety
por: Alghamdi, Sami A
Publicado: (2023)

Technical Tips and Tricks after 10 Years of HyFoSy for Tubal Patency Testing
por: Bohîlțea, Roxana-Elena, et al.
Publicado: (2022)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents
por: Rees, Julian A., et al.
Publicado: (2018)

The Effect of Magnetic Field Gradient and Gadolinium-Based MRI Contrast Agent Dotarem on Mouse Macrophages
por: Chanana, Priyanka, et al.
Publicado: (2022)

Nonsteroidal Anti-Inflammatory Drug Conjugated with Gadolinium (III) Complex as an Anti-Inflammatory MRI Agent
por: Sung, Bokyung, et al.
Publicado: (2023)

Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium‐Based Contrast Agents
por: Yao, Xiang, et al.
Publicado: (2022)

Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft
por: Luo, Xuefeng, et al.
Publicado: (2019)

Long-term intra-arterial shunt
por: Feliciano, David V
Publicado: (2020)

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
por: Robert, Philippe, et al.
Publicado: (2016)

Incidental MRI Findings of Acute Gadolinium Hypersensitivity
por: Amene, C., et al.
Publicado: (2012)

The Use of Gadolinium in Musculoskeletal MRI—Time to Rethink?
por: Elawad, Arwa, et al.
Publicado: (2021)

TIPS Modification in the Management of Shunt-Induced Hepatic Encephalopathy: Analysis of Predictive Factors and Outcome with Shunt Modification
por: Schindler, Philipp, et al.
Publicado: (2020)

Pre-Liver Transplant: Tips Versus Distal Splenorenal Shunt
por: Faust, Thomas W., et al.
Publicado: (1997)

Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS)
por: Krajina, Antonin, et al.
Publicado: (2012)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)

Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents
por: Silva, Simone Rodrigues, et al.
Publicado: (2015)

The potential toxic impact of different gadolinium-based contrast agents combined with 7-T MRI on isolated human lymphocytes
por: Friebe, Björn, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5fgb3590sjusnv8p3psbc07gqq